Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

α-Methyltryptamine

From Wikipedia, the free encyclopedia
(Redirected fromΑ-methyltryptamine)
Chemical compound

Pharmaceutical compound
α-Methyltryptamine
Clinical data
Trade namesIndopan; Indopane
Other namesalpha-Methyltryptamine; αMT; α-ET; AMT; IT-290; IT-403 ((+)-αMT); NSC-97069; PAL-17;[1] Ro 3-0926; U-14,164E; U-14,164-E; 3-(2-Aminopropyl)indole; 3-API; 3-IT; α-Methyl-3-indoleethanamine; Metryptamine; Amtryptamine
Routes of
administration
Oral,insufflation,rectal,smoked,IM,IV[2]
Drug classEntactogen;Stimulant;Psychedelic;Hallucinogen;Monoamine releasing agent;Serotonin receptor agonist;Monoamine oxidase inhibitor
ATC code
  • None
Legal status
Legal status
Pharmacokinetic data
Onset of action3–4 hours[4]
Duration of action12–24 hours[4]
Identifiers
  • 1-(1H-Indol-3-yl)propan-2-amine
CAS Number
PubChemCID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.005.522Edit this at Wikidata
Chemical and physical data
FormulaC11H14N2
Molar mass174.247 g·mol−1
3D model (JSmol)
  • NC(CC1=CNC2=C1C=CC=C2)C
  • InChI=1S/C11H14N2/c1-8(12)6-9-7-13-11-5-3-2-4-10(9)11/h2-5,7-8,13H,6,12H2,1H3 checkY
  • Key:QSQQQURBVYWZKJ-UHFFFAOYSA-N checkY
  (verify)

α-Methyltryptamine (αMT,AMT) is apsychedelic,stimulant, andentactogendrug of thetryptamine family.[5][6] It was originally developed as anantidepressant atUpjohn in the 1960s, and was used briefly as an antidepressant in theSoviet Union under the brand nameIndopan orIndopane before being discontinued.[4][7][8]

Side effects of αMT includeagitation,restlessness,confusion,lethargy,pupil dilation,jaw clenching, andrapid heart rate, among others.[4][9] αMT acts as areleasing agent of serotonin, norepinephrine, and dopamine, as aserotonin receptor agonist, and as a weakmonoamine oxidase inhibitor.[1] αMT is asubstituted tryptamine and is closely related toα-ethyltryptamine (αET) and otherα-alkylated tryptamines.[1][5]

αMT appears to have first been described by at least 1929.[10][11] It started being more studied in the late 1950s and was briefly used as anantidepressant in theSoviet Union in the 1960s.[4][12][9][13][14] The drug started being usedrecreationally in the 1960s, with use increasing in the 1990s, and cases of death have been reported.[4][13][9][12] αMT is acontrolled substance in various countries, including theUnited States.[13][4]

Medical uses

[edit]

Under the brand name Indopan or Indopane, αMT at doses of 5 to 10 mg was used for anantidepressant effect.[medical citation needed]

Effects

[edit]

With 20 to 30 mg,euphoria,empathy, andpsychedelic effects become apparent and can last as long as 12 hours.[15] A dose exceeding 40 mg is generally considered strong. In rare cases or extreme doses, the duration of effects might exceed 24 hours. Users report that αMT infreebaseform issmoked, with doses between and 2 and 5 mg.[2][unreliable source?][5]

Side effects

[edit]

Neurologic side effects of αMT includeagitation,restlessness,confusion, andlethargy.[4][9] Physical manifestations includingvomiting,mydriasis (pupillary dilation),jaw clenching,tachycardia,salivation,diaphoresis (sweating), andelevations in blood pressure,temperature, andrespiratory rate.[4][9]

Side effects self-reported by recreational users includeanxiety,muscle tension,jaw tightness,pupil dilation,tachycardia,headaches,nausea, andvomiting, as well aspsychedelic effects including visual hallucinations and an altered state of mind.[5][16]

αMT is capable of causing life-threatening side effects includinghyperthermia,hypertension, andtachycardia.[9][17] Fatalities have been reported in association with high doses or concomitant use of other drugs.[18] Fatalities verified with toxicology and autopsy include those of a 22-year-old man inMiami-Dade county and a British teenager, both of whom died after consuming 1 g of αMT.[19][9]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Pharmacology

[edit]

Pharmacodynamics

[edit]

αMT acts as a relatively balancedreuptake inhibitor andreleasing agent of the main threemonoamines;serotonin,norepinephrine, anddopamine,[20] and as a non-selectiveserotonin receptoragonist.[21]

Activities of αMT and related compounds
CompoundMonoamine release (EC50Tooltip half-maximal effective concentration, nM)5-HT2A receptoragonism
SerotoninDopamineNorepinephrineEC50Tooltip half-maximal effective concentration (nM)Emax (%)
Tryptamine331647167.4104
Serotonin44>10,000>10,000NDND
N,N-DMT114>10,0004,1663883
αMT22–6879–11279–18023103
αET23232640 (EmaxTooltip maximal efficacy = 78%)>10,00021
5-MeO-αMT4608,9001,5002.0–8.4ND
MDMA5737677NDND
Notes: The smaller the value, the more strongly the compound produces the effect.Refs:[22][1][23][24][25]

Monoamine oxidase inhibition

[edit]

αMT has been shown as areversibleinhibitor of theenzymemonoamine oxidase (MAO)in vitro[26] andin vivo.[27] In rats, the potency of αMT as an MAO-A inhibitor in the brain was approximately equal to that ofharmaline at equimolar doses.[note 1] Dextroamphetamine did not enhance the5-hydroxytryptophan-induced rise of serotonin at any level.[28] TheIC50Tooltip half-maximal inhibitory concentration of αMT for inhibition of MAO-A has been found to be 380 nM.[29] This is similar to that of agents likepara-methoxyamphetamine (PMA) and4-methylthioamphetamine (4-MTA).[30]

Serotonergic neurotoxicity

[edit]

A closeanalogue of αMT,α-ethyltryptamine (αET), is known to be aserotonergic neurotoxin similarly toMDMA andpara-chloroamphetamine (PCA).[31][22][32]

Pharmacokinetics

[edit]

2-Oxo-αMT, 6-hydroxy-αMT, 7-hydroxy-αMT, and 1′-hydroxy-αMT were detected asmetabolites of αMT in maleWistar rats.[4][33][34]

Chemistry

[edit]

αMT is asyntheticsubstituted tryptamine with amethylsubstituent at thealpha carbon.[1][9] This alpha substitution makes it a relatively poorsubstrate formonoamine oxidase A, thereby prolonging αMT's half-life, allowing it to reach the brain and enter the central nervous system. Its chemical relation to tryptamine is analogous to that ofamphetamine tophenethylamine, amphetamine being α-methylphenethylamine.[9] αMT is closely related to theneurotransmitterserotonin (5-hydroxytryptamine) which partially explains itsmechanism of action.

Manyanalogues of αMT are known, includingα-ethyltryptamine (αET),4-methyl-αMT,5-chloro-αMT (PAL-542),5-fluoro-αMT (PAL-544),5-fluoro-αET (PAL-545),5-methoxy-αMT (5-MeO-αMT),α,N-dimethyltryptamine (α,N-DMT;N-methyl-αMT),α,N,N-trimethyltryptamine (α,N,N-TMT;N-dimethyl-αMT),α-methylserotonin (α-methyl-5-HT; 5-hydroxy-αMT), andindolylpropylaminopentane (IPAP; α,N-dipropyltryptamine or α,N-DPT), among others.[1][5] Another analogue of αMT is the β-keto andN-methylatedderivativeBK-NM-AMT.[35][36][37]

α-Methyltryptophan, aprodrug ofα-methylserotonin, alsometabolizes into αMT, but only in small amounts.[38][39][40]

Synthesis

[edit]

The synthesis of αMT can be accomplished through several different routes, the two most widely known being the nitroaldol condensation betweenindole-3-carboxaldehyde andnitroethane underammonium acetate catalysis which produces 1-(3-indolyl)-2-nitropropene-1, the product can subsequently be reduced using a reducing agent likelithium aluminum hydride[41] The alternative synthesis is the condensation between indole-3-acetone andhydroxylamine.[citation needed], followed by reduction of the obtained ketoxime withlithium aluminum hydride.[5]

History

[edit]

αMT has been said to have been firstsynthesized in 1947, alongsideα-ethyltryptamine (αET).[12][22][42] However, other sources suggest that αMT was first described in thescientific literature by at least 1929.[10][11] It was specifically described as anantagonist ofergotamine at this time.[10][11]

αMT started to be more intensively studied, along with αET, in the late 1950s and early 1960s.[12][43][44][45][28][46][47][48][49][50] It was researched byUpjohn (code name U-14,164E) andSandoz (code name IT-290) as a possiblepharmaceutical drug and was simultaneously marketed in theSoviet Union as anantidepressant under the brand name Indopan or Indopane in the 1960s.[13][14][9][51] However, the drug was used clinically for only a short period of time before beingwithdrawn.[14]

αMT started being used as arecreational drug in the 1960s[9] and use as adesigner drug increased in the 1990s.[13] It became acontrolled substance in theUnited States in 2003.[13]

Society and culture

[edit]

Names

[edit]

αMT never received a formalgeneric name.[52] In thescientific literature, it has been referred to asα-methyltryptamine oralpha-methyltryptamine (abbreviated asα-MT,αMT, orAMT).[13][14] αMT has also been referred to by developmental code names includingIT-290 (Sandoz),[53]NSC-97069,[12]PAL-17,[1]Ro 3-0926,[54][55] andU-14,164E (Upjohn).[56][57][12][9] In theSoviet Union, the drug was merely referred to by its brand nameIndopan orIndopane.[58][9] Other synonyms of αMT include3-(2-aminopropyl)indole and3-IT.[12] (+)-αMT has been referred to by the code nameIT-403.[12][9]

Legality

[edit]

Australia

[edit]

The 5-methoxy analogue,5-MeO-αMT isschedule 9 in Australia and αMT would be controlled as an analogue of this.[59]

Austria

[edit]

αMT is placed under Austrian law (NPSG) Group 6.[60]

Canada

[edit]

Canada has no mention of αMT in theControlled Drugs and Substances Act.[61]

China

[edit]

As of October 2015 αMT is a controlled substance in China.[62]

Denmark

[edit]

In Denmark (2010), the Danish Minister for the Interior and Health placed αMT to their lists of controlled substances (List B).[60]

Finland

[edit]

AMT, alfa-methyltryptamine, is a controlled drug in Finland.[63]

Germany

[edit]

αMT is listed under the Narcotics Act in schedule 1 (narcotics not eligible for trade and medical prescriptions) in Germany.[60]

Hungary

[edit]

αMT was controlled on the Schedule C list in Hungary in 2013.[60]

Lithuania

[edit]

In Lithuania (2012), αMT is controlled as a tryptamine derivative put under control in the 1st list of Narcotic Drugs and Psychotropic Substances which use is prohibited for medical purposes.[60]

Slovakia

[edit]

αMT was placed in 2013 on the List of Hazardous Substances in Annex, § 2 in Slovakia.[60]

Slovenia

[edit]

αMT appeared on the Decree on Classification of Illicit Drugs in Slovenia (2013).[60]

Spain

[edit]

αMT is legal in Spain.[64]

Sweden

[edit]

Sveriges riksdags health ministryStatens folkhälsoinstitut classified αMT as "health hazard" under the actLagen om förbud mot vissa hälsofarliga varor (translatedAct on the Prohibition of Certain Goods Dangerous to Health) as of Mar 1, 2005, in their regulation SFS 2005:26 listed as alfa-metyltryptamin (AMT), making it illegal to sell or possess.[65]

United Kingdom

[edit]

αMT was made illegal in the United Kingdom as of 7 January 2015, along with5-MeO-DALT.[66]This was following the events of 10 June 2014 when theAdvisory Council on the Misuse of Drugs recommended that αMT be scheduled as a class A drug by updating the blanket ban clause on tryptamines.[67]

United States

[edit]

TheDrug Enforcement Administration (DEA) placed αMT temporarily in schedule I of the Controlled Substances Act (CSA) on April 4, 2003, pursuant to the temporary scheduling provisions of the CSA (68 FR16427). On September 29, 2004, αMT was permanently controlled as a schedule I substance under the CSA (69FR 58050).[68]

Research

[edit]

Besidesdepression, αMT has been studied in people withschizophrenia and other conditions.[1]

See also

[edit]

Notes

[edit]
  1. ^MAOI potency was comparable at 7 μM/kg, equivalent to 1.5 mg/kg of Harmaline and 1.2 mg/kg of αMT. At 70 μM/kg αMT was a much less effective MAOI than harmaline.[28]

References

[edit]
  1. ^abcdefghBlough BE, Landavazo A, Partilla JS, Decker AM, Page KM, Baumann MH, et al. (October 2014)."Alpha-ethyltryptamines as dual dopamine-serotonin releasers".Bioorganic & Medicinal Chemistry Letters.24 (19):4754–4758.doi:10.1016/j.bmcl.2014.07.062.PMC 4211607.PMID 25193229.
  2. ^abDialtonez (12 March 2003)."AMT FAQ".Erowid Vault.
  3. ^Anvisa (2023-07-24)."RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese).Diário Oficial da União (published 2023-07-25).Archived from the original on 2023-08-27. Retrieved2023-08-27.
  4. ^abcdefghijBarceloux DG (20 March 2012).Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants. John Wiley & Sons. pp. 196–199.ISBN 978-0-471-72760-6.
  5. ^abcdef"#48 a-MT".Erowid Online Books: TIHKAL.
  6. ^"AMT (alpha-methyltryptamine)".Erowid Vault.
  7. ^Iversen L (11 November 2013).Handbook of Psychopharmacology: Volume 14 Affective Disorders: Drug Actions in Animals and Man. Springer Science & Business Media. pp. 132–.ISBN 978-1-4613-4045-4.
  8. ^Halberstadt AL, Geyer MA (17 May 2013)."Neuropharmacology of lysergic acid diethylamide (LSD) and other hallucinogens.". In Miller PM, Ball SA, Bates ME, Blume AW, Kampman KM, Kavanagh DJ, Larimer ME, Petry NM, De Witte P (eds.).Biological Research on Addiction: Comprehensive Addictive Behaviors and Disorders. Vol. 2. Academic Press. pp. 625–635 (632).doi:10.1016/B978-0-12-398335-0.00061-3.ISBN 978-0-12-398360-2.
  9. ^abcdefghijklmnBoland DM, Andollo W, Hime GW, Hearn WL (July–August 2005)."Fatality due to acute alpha-methyltryptamine intoxication".Journal of Analytical Toxicology.29 (5):394–397.doi:10.1093/jat/29.5.394.PMID 16105268.α-Methyltryptamine (AMT) is a synthetic drug of the tryptamine family. It is an indole analogue of amphetamine initially investigated as a monoamine oxidase inhibitor. In the 1960s, the Soviet Union marketed AMT as an antidepressant under the name of Indopan. During the same period, Sandoz (as IT-290 and IT-403) and the Upjohn Company (as [U-14,164E]) studied AMT and its commercial use as a stimulant, but found it to be of little medicinal value. Although clinical use of AMT is obsolete today, recreational use has gained popularity because of the intense hallucinogenic properties lasting up to 16 h. To illustrate recreational use of AMT in the 1960s, Alexander Shulgin, in his book TiHKAL, references the author Ken Kesey and his experiences with AMT and other hallucinogenic drugs (1).
  10. ^abcGaddum JH, Hameed KA (June 1954)."Drugs which antagonize 5-hydroxytryptamine".British Journal of Pharmacology and Chemotherapy.9 (2):240–248.doi:10.1111/j.1476-5381.1954.tb00848.x.PMC 1509436.PMID 13172437.The antagonism of ergotoxine and tryptamine was described by Laidlaw (1911) and that of ergotamine and α-methyltryptamine by Seki (1929).
  11. ^abcSeki J (1929)."Pharmakologische Untersuchungen des α-Methyl-β-indoläthylamins" [Pharmacological studies of α-methyl-β-indoleethylamine].Japanese Journal of Medical Sciences. Part 4: Pharmacology.3. National Research Council of Japan:235–285.ISSN 0368-3745.OCLC 610325817.
  12. ^abcdefghElliott SP, Brandt SD, Freeman S, Archer RP (March 2013). "AMT (3-(2-aminopropyl)indole) and 5-IT (5-(2-aminopropyl)indole): an analytical challenge and implications for forensic analysis".Drug Testing and Analysis.5 (3):196–202.doi:10.1002/dta.1420.PMID 23042766.α-Methyltryptamine (2, 3-(2-aminopropyl)indole, AMT, α-MT, 3-IT, IT-290, IT-403, U-14, 162-E, Ro 3-0926, NSC 97069, Indopan; Figure 1), on the other hand, is a positional isomer of 5-IT that also shows long-lasting psychoactive effects in humans[1] although further studies are needed to determine the differences or similarities between both psychopharmacological profiles. Following its first synthesis in 1947,[5] the interest in AMT, and other α-alkylated tryptamines, began to develop in the late 1950s when it was discovered that some of these analogues also displayed monoamine oxidase (MAO) inhibiting properties.[6,7] [...]
  13. ^abcdefgAraújo AM, Carvalho F, Bastos Md, Guedes de Pinho P, Carvalho M (August 2015). "The hallucinogenic world of tryptamines: an updated review".Archives of Toxicology.89 (8):1151–1173.doi:10.1007/s00204-015-1513-x.PMID 25877327.
  14. ^abcdTittarelli R, Mannocchi G, Pantano F, Romolo FS (January 2015)."Recreational use, analysis and toxicity of tryptamines".Current Neuropharmacology.13 (1):26–46.doi:10.2174/1570159x13666141210222409.PMC 4462041.PMID 26074742.
  15. ^Wilcox J (2012). "Psychoactive properties of alpha-methyltryptamine: analysis from self reports of users".Journal of Psychoactive Drugs.44 (3):274–276.doi:10.1080/02791072.2012.704592.PMID 23061328.S2CID 38340985.
  16. ^"AMT Effects".Erowid Vault.
  17. ^Gillman PK (October 2005)."Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity".British Journal of Anaesthesia.95 (4):434–441.doi:10.1093/bja/aei210.PMID 16051647. "drugs such as MDMA, ecstasy (3,4-methylenedioxymethamphetamine), if combined with MAOIs (including moclobemide) do also cause fatalities because they act as serotonin releasers"
  18. ^"Call for ban on drug after reveller's death".Western Gazette. 22 March 2012. Archived fromthe original on 16 October 2013. Retrieved1 October 2013.
  19. ^"Southampton 'legal high' death deemed 'accidental'".BBC News. 12 November 2013. Retrieved19 November 2013.
  20. ^Nagai F, Nonaka R, Satoh Hisashi Kamimura K (March 2007). "The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain".European Journal of Pharmacology.559 (2–3):132–137.doi:10.1016/j.ejphar.2006.11.075.PMID 17223101.
  21. ^Nonaka R, Nagai F, Ogata A, Satoh K (December 2007)."In vitro screening of psychoactive drugs by [(35)S]GTPgammaS binding in rat brain membranes".Biological & Pharmaceutical Bulletin.30 (12):2328–2333.doi:10.1248/bpb.30.2328.PMID 18057721.
  22. ^abcGlennon RA, Dukat MG (December 2023)."α-Ethyltryptamine: A Ratiocinatory Review of a Forgotten Antidepressant".ACS Pharmacology & Translational Science.6 (12):1780–1789.doi:10.1021/acsptsci.3c00139.PMC 10714429.PMID 38093842.
  23. ^Blough BE, Landavazo A, Decker AM, Partilla JS, Baumann MH, Rothman RB (October 2014)."Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes".Psychopharmacology (Berl).231 (21):4135–4144.doi:10.1007/s00213-014-3557-7.PMC 4194234.PMID 24800892.
  24. ^Rothman RB, Baumann MH (October 2003). "Monoamine transporters and psychostimulant drugs".Eur J Pharmacol.479 (1–3):23–40.doi:10.1016/j.ejphar.2003.08.054.PMID 14612135.
  25. ^Nagai F, Nonaka R, Satoh Hisashi Kamimura K (March 2007). "The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain".Eur J Pharmacol.559 (2–3):132–137.doi:10.1016/j.ejphar.2006.11.075.PMID 17223101.
  26. ^Arai Y, Toyoshima Y, Kinemuchi H (June 1986)."Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. II. Inhibition by alpha-methylated substrate-analogue monoamines, alpha-methyltryptamine, alpha-methylbenzylamine and two enantiomers of alpha-methylbenzylamine".Japanese Journal of Pharmacology.41 (2):191–197.doi:10.1254/jjp.41.191.PMID 3747266.
  27. ^Greig ME, Walk RA, Gibbons AJ (October 1959)."The effect of three tryptamine derivatives on serotonin metabolism in vitro and in vivo".The Journal of Pharmacology and Experimental Therapeutics.127:110–115.PMID 13851725.
  28. ^abcGey KF, Pletscher A (August 1962)."Effect of alpha-alkylated tryptamine derivatives on 5-hydroxytryptamine metabolism in vivo".British Journal of Pharmacology and Chemotherapy.19 (1):161–167.doi:10.1111/j.1476-5381.1962.tb01437.x.PMC 1482243.PMID 13898151.
  29. ^Wagmann L, Brandt SD, Kavanagh PV, Maurer HH, Meyer MR (April 2017)."In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks"(PDF).Toxicol Lett.272:84–93.doi:10.1016/j.toxlet.2017.03.007.PMID 28302559.
  30. ^Reyes-Parada M, Iturriaga-Vasquez P, Cassels BK (2019)."Amphetamine Derivatives as Monoamine Oxidase Inhibitors".Front Pharmacol.10: 1590.doi:10.3389/fphar.2019.01590.PMC 6989591.PMID 32038257.
  31. ^Oeri HE (May 2021)."Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy".Journal of Psychopharmacology.35 (5):512–536.doi:10.1177/0269881120920420.PMC 8155739.PMID 32909493.
  32. ^Huang XM, Johnson MP, Nichols DE (July 1991). "Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase)".European Journal of Pharmacology.200 (1):187–190.doi:10.1016/0014-2999(91)90686-k.PMID 1722753.
  33. ^Szara S (February 1961)."6-Hydroxylation: an important metabolic route for alpha-methyltryptamine".Experientia.17 (2):76–77.doi:10.1007/BF02171429.PMID 13774483.S2CID 27030395.
  34. ^Kanamori T, Kuwayama K, Tsujikawa K, Miyaguchi H, Iwata YT, Inoue H (December 2008). "In vivo metabolism of alpha-methyltryptamine in rats: identification of urinary metabolites".Xenobiotica; the Fate of Foreign Compounds in Biological Systems.38 (12):1476–1486.doi:10.1080/00498250802491654.PMID 18982537.S2CID 20637936.
  35. ^Blough BE, Decker AM, Landavazo A, Namjoshi OA, Partilla JS, Baumann MH, et al. (March 2019)."The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomes".Psychopharmacology (Berl).236 (3):915–924.doi:10.1007/s00213-018-5063-9.PMC 6475490.PMID 30341459.
  36. ^US 20240335414, Matthew J. Baggott & Sean Dalziel, "Specialized combinations for mental disorders or mental enhancement", published 10 October 2024, assigned toTactogen Inc. 
  37. ^WO 2022061242, Matthew Baggott, "Advantageous tryptamine compositions for mental disorders or enhancement", published 2023 March 24, assigned toTactogen 
  38. ^Sourkes TL (1991). "Alpha-methyltryptophan as a therapeutic agent".Prog Neuropsychopharmacol Biol Psychiatry.15 (6):935–938.doi:10.1016/0278-5846(91)90020-2.PMID 1763198.
  39. ^Roberge AG, Missala K, Sourkes TL (March 1972). "Alpha-methyltryptophan: effects on synthesis and degradation of serotonin in the brain".Neuropharmacology.11 (2):197–209.doi:10.1016/0028-3908(72)90092-5.PMID 4260268.
  40. ^Marsden CA, Curzon G (1977). "Effects of p-chlorophenylalanine and alpha-methyltryptophan on behaviour and brain 5-hydroxyindoles".Neuropharmacology.16 (7–8):489–494.doi:10.1016/0028-3908(77)90006-5.PMID 144245.
  41. ^Anonymous."Synthesis of alpha-Methyltryptamine (IT-290/AMT)".TheHive. Retrieved7 June 2023.
  42. ^Snyder HR, Katz L (December 1947). "The alkylation of aliphatic nitro compounds with gramine; a new synthesis of derivatives of tryptamine".Journal of the American Chemical Society.69 (12):3140–3142.doi:10.1021/ja01204a061.PMID 18919717.
  43. ^Greig ME, Walk RA, Gibbons AJ (October 1959). "The effect of three tryptamine derivatives on serotonin metabolism in vitro and in vivo".The Journal of Pharmacology and Experimental Therapeutics.127:110–115.PMID 13851725.
  44. ^Heinzelman RV, Anthony WC, Lyttle DA, Szmuszkovicz J (1960). "The Synthesis of α-Methyltryptophans and α-Alkyltryptamines".The Journal of Organic Chemistry.25 (9):1548–1558.doi:10.1021/jo01079a021.ISSN 0022-3263.
  45. ^Murphree HB, Dippy RH, Jenney EH, Pfeiffer CC (1961). "Effects in normal man of alpha-methyltryptamine and alpha-ethyltryptamine".Clinical Pharmacology and Therapeutics.2 (6):722–726.doi:10.1002/cpt196126722.PMID 14477400.
  46. ^Himwich HE (February 1961). "Experiments with alpha-methyltryptamine".Journal of Neuropsychiatry.2 (Suppl 1):136–140.PMID 13714418.
  47. ^Vane JR, Collier HO, Corne SJ, Marley E, Bradley PB (September 1961). "Tryptamine receptors in the central nervous system".Nature.191 (4793):1068–1069.doi:10.1038/1911068a0.PMID 13780152.
  48. ^Keller JG, Viguera C, Kundzins W (November 1962). "Studies on the toxicology of alpha-methyl- and alpha-ethyltryptamine acetates (Monase). II. Chronic studies".Toxicology and Applied Pharmacology.4 (6):697–709.doi:10.1016/0041-008x(62)90099-6.PMID 14031765.
  49. ^Szara S, Hearst E, Putney F (1962). "Metabolism and behavioural action of psychotropic tryptamine homologues".International Journal of Neuropharmacology.1 (1–3):111–117.doi:10.1016/0028-3908(62)90015-1.
  50. ^Mashkovskii MD, Trubitsyna TK (1963). "[Pharmacological properties of indopane (alpha-methyltryptamine HCl)]".Zhurnal Nevropatologii I Psikhiatrii imeni S.S. Korsakova (in Russian).63:72–79.PMID 13933321.
  51. ^US Patent 3296072, Szmuszkovicz J, "Method of Treating Mental Depression", published 1967-01-03, assigned to Upjohn Co. 
  52. ^Elks J (2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US.ISBN 978-1-4757-2085-3. Retrieved7 September 2024.
  53. ^Hollister LE, Prusmack JJ, Paulsen A, Rosenquist N (November 1960). "Comparison of three psychotropic drugs (psilocybin, JB-329, and IT-290) in volunteer subjects".The Journal of Nervous and Mental Disease.131 (5):428–434.doi:10.1097/00005053-196011000-00007.PMID 13715375.
  54. ^Lessin AW, Long RF, Parkes MW (April 1966). "Conversion of indolylalkylhydroxylamines to stimulant amines in vivo".Biochemical Pharmacology.15 (4):481–487.doi:10.1016/0006-2952(66)90258-9.PMID 5954980.
  55. ^Lessin AW, Long RF, Parkes MW (January 1967)."The central stimulant properties of some substituted indolylalkylamines and beta-carbolines and their activities as inhibitors of monoamine oxidase and the uptake of 5-hydroxytryptamine".British Journal of Pharmacology and Chemotherapy.29 (1):70–79.doi:10.1111/j.1476-5381.1967.tb01940.x.PMC 1557188.PMID 19108241.
  56. ^Burningham RA, Arimura GK, Yunis AA (July 1966). "Effect of Monase and related compounds on uptake of 5-hydroxytryptamine by platelets".Proceedings of the Society for Experimental Biology and Medicine.122 (3):711–714.doi:10.3181/00379727-122-31233.PMID 5918937.
  57. ^Offermeier J (1965).Serotonin and its derivatives: a study on structure-activity relations (Ph.D. thesis). Catholic University of Nijmegen. Retrieved7 September 2024.
  58. ^"("indopan"[title] OR "indopane"[title])".PubMed. U.S. National Library of Medicine. Retrieved7 September 2024.
  59. ^"5-MeO-AMT: Legal Status".Erowid Vault.
  60. ^abcdefgExpert Committee on Drug Dependence Thirty-sixth Meeting (June 2014)."Alpha-methyltryptamine (AMT) Critical Review Report Agenda item 4.20"(PDF). Geneva: World Health Organization (WHO). Archived fromthe original(PDF) on 16 September 2018.
  61. ^"CSDA". Archived fromthe original on 2011-09-28. Retrieved2011-06-05.
  62. ^"关于印发《非药用类麻醉药品和精神药品列管办法》的通知" [Notice on the issuance of the "Regulations on the Listing of Non-Medicinal Narcotic Drugs and Psychotropic Drugs"] (in Chinese). China Food and Drug Administration. 27 September 2015. Archived fromthe original on 1 October 2015. Retrieved1 October 2015.
  63. ^"Lääkeluettelon Aineet, Liite 1, Bilaga 1.3" [Substances of the drug list, Appendix 1. Attachment 1.3](PDF).Finlex Data Bank. Finnish Ministry of Justice. Archived fromthe original(PDF) on May 10, 2015.
  64. ^"Medicamentos de Uso Humano - Estupefacientes y Psicótropos" [Medicines for Human Use - Narcotics and Psychotropic Substances].Agencia Española de Medicamentos y Productos Sanitarios [Spanish Agency for Medicines and Health Products]. Archived fromthe original on 2019-01-02. Retrieved2019-01-01.
  65. ^"Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor [Ordinance amending the Ordinance (1999:58) on the prohibition of certain goods hazardous to health]"(PDF),Lagen om förbud mot vissa hälsofarliga varor - SFS 2005:26 [The Act on the Prohibition of Certain Goods Hazardous to Health - SFS 2005:26] (in Swedish), February 2005, archived fromthe original(PDF) on 2013-09-29, retrieved2013-10-07
  66. ^"The Misuse of Drugs (Amendment No. 3) (England, Wales and Scotland) Regulations 2014".www.legislation.gov.uk.
  67. ^ACMD (10 June 2014)."Update of the Generic Definition for Tryptamines"(PDF). UK Home Office. p. 12. Retrieved10 June 2014.
  68. ^"Alpha-methyltryptamine"(PDF).DEA Office of Diversion Control. April 2013.Archived(PDF) from the original on 2013-10-17. Retrieved2013-10-10.

External links

[edit]
SSRIsTooltip Selective serotonin reuptake inhibitors
SNRIsTooltip Serotonin–norepinephrine reuptake inhibitors
NRIsTooltip Norepinephrine reuptake inhibitors
NDRIsTooltip Norepinephrine–dopamine reuptake inhibitors
NaSSAsTooltip Noradrenergic and specific serotonergic antidepressants
SARIsTooltip Serotonin antagonist and reuptake inhibitors
SMSTooltip Serotonin modulator and stimulators
Others
TCAsTooltip Tricyclic antidepressants
TeCAsTooltip Tetracyclic antidepressants
Others
Non-selective
MAOATooltip Monoamine oxidase A-selective
MAOBTooltip Monoamine oxidase B-selective
Miscellaneous
Phenethylamines
Non-ring-extended
Benzodioxoles
(methylenedioxy- or MDxx)
Benzodioxines
(ethylenedioxy-)
Benzofurans
Dihydrobenzofurans
Benzothiophenes
Benzothiazoles
Benzoxathioles
Indanes
Indoles
Naphthalenes
Tetralins
Others
Cyclized
phenethylamines
Aminoindanes
Aminotetralins
Aminorexes
Tryptamines
α-Alkyltryptamines
Others
Benzofurans
Benzothiophenes
Indolizines
Isotryptamines
Others
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
25x-NB (NBOMes)
2C-x
3C-x
4C-x
Cyclized
DOx
FLY
MDxx
Scalines
Others
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
Adamantanes
Adenosine antagonists
Alkylamines
Ampakines
Arylcyclohexylamines
Benzazepines
Cathinones
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Phenylmorpholines
Piperazines
Piperidines
Pyrrolidines
Racetams
Tropanes
Tryptamines
Others
DRAsTooltip Dopamine releasing agents
NRAsTooltip Norepinephrine releasing agents
SRAsTooltip Serotonin releasing agents
Others
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Non-specific
AAADTooltip Aromatic L-amino acid decarboxylase
MAOTooltip Monoamine oxidase
Phenethylamines
(dopamine,epinephrine,
norepinephrine)
PAHTooltip Phenylalanine hydroxylase
THTooltip Tyrosine hydroxylase
DBHTooltip Dopamine beta-hydroxylase
PNMTTooltip Phenylethanolamine N-methyltransferase
COMTTooltip Catechol-O-methyl transferase
Tryptamines
(serotonin,melatonin)
TPHTooltip Tryptophan hydroxylase
AANATTooltip Serotonin N-acetyl transferase
ASMTTooltip Acetylserotonin O-methyltransferase
Histamine
HDCTooltip Histidine decarboxylase
HNMTTooltip Histamine N-methyltransferase
DAOTooltip Diamine oxidase
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
Triptans
Cyclized tryptamines
Isotryptamines
Related compounds
Stimulants
Depressants
Hallucinogens
Entactogens
Psychiatric drugs
Others
Retrieved from "https://en.wikipedia.org/w/index.php?title=Α-Methyltryptamine&oldid=1289593705"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp